Literature DB >> 28753430

Defining a Cancer Dependency Map.

Aviad Tsherniak1, Francisca Vazquez2, Phil G Montgomery1, Barbara A Weir2, Gregory Kryukov2, Glenn S Cowley1, Stanley Gill2, William F Harrington1, Sasha Pantel1, John M Krill-Burger1, Robin M Meyers1, Levi Ali1, Amy Goodale1, Yenarae Lee1, Guozhi Jiang1, Jessica Hsiao1, William F J Gerath1, Sara Howell1, Erin Merkel1, Mahmoud Ghandi1, Levi A Garraway3, David E Root1, Todd R Golub4, Jesse S Boehm1, William C Hahn5.   

Abstract

Most human epithelial tumors harbor numerous alterations, making it difficult to predict which genes are required for tumor survival. To systematically identify cancer dependencies, we analyzed 501 genome-scale loss-of-function screens performed in diverse human cancer cell lines. We developed DEMETER, an analytical framework that segregates on- from off-target effects of RNAi. 769 genes were differentially required in subsets of these cell lines at a threshold of six SDs from the mean. We found predictive models for 426 dependencies (55%) by nonlinear regression modeling considering 66,646 molecular features. Many dependencies fall into a limited number of classes, and unexpectedly, in 82% of models, the top biomarkers were expression based. We demonstrated the basis behind one such predictive model linking hypermethylation of the UBB ubiquitin gene to a dependency on UBC. Together, these observations provide a foundation for a cancer dependency map that facilitates the prioritization of therapeutic targets.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RNAi screens; cancer dependencies; cancer targets; genetic vulnerabilities; genomic biomarkers; precision medicine; predictive modeling; seed effects; shRNA

Mesh:

Substances:

Year:  2017        PMID: 28753430      PMCID: PMC5667678          DOI: 10.1016/j.cell.2017.06.010

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  56 in total

1.  Noise amidst the silence: off-target effects of siRNAs?

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

2.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

3.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

Authors:  Richard Marcotte; Kevin R Brown; Fernando Suarez; Azin Sayad; Konstantina Karamboulas; Paul M Krzyzanowski; Fabrice Sircoulomb; Mauricio Medrano; Yaroslav Fedyshyn; Judice L Y Koh; Dewald van Dyk; Bodhana Fedyshyn; Marianna Luhova; Glauber C Brito; Franco J Vizeacoumar; Frederick S Vizeacoumar; Alessandro Datti; Dahlia Kasimer; Alla Buzina; Patricia Mero; Christine Misquitta; Josee Normand; Maliha Haider; Troy Ketela; Jeffrey L Wrana; Robert Rottapel; Benjamin G Neel; Jason Moffat
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

4.  Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.

Authors:  John M Ashton; Marlene Balys; Sarah J Neering; Duane C Hassane; Glenn Cowley; David E Root; Peter G Miller; Benjamin L Ebert; Helene R McMurray; Hartmut Land; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2012-08-02       Impact factor: 24.633

5.  Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.

Authors:  Boris G Wilson; Katherine C Helming; Xiaofeng Wang; Youngha Kim; Francisca Vazquez; Zainab Jagani; William C Hahn; Charles W M Roberts
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

6.  Passenger deletions generate therapeutic vulnerabilities in cancer.

Authors:  Florian L Muller; Simona Colla; Elisa Aquilanti; Veronica E Manzo; Giannicola Genovese; Jaclyn Lee; Daniel Eisenson; Rujuta Narurkar; Pingna Deng; Luigi Nezi; Michelle A Lee; Baoli Hu; Jian Hu; Ergun Sahin; Derrick Ong; Eliot Fletcher-Sananikone; Dennis Ho; Lawrence Kwong; Cameron Brennan; Y Alan Wang; Lynda Chin; Ronald A DePinho
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

7.  Lenalidomide induces degradation of IKZF1 and IKZF3.

Authors:  Jan Krönke; Slater N Hurst; Benjamin L Ebert
Journal:  Oncoimmunology       Date:  2014-07-03       Impact factor: 8.110

8.  gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens.

Authors:  Fabian Schmich; Ewa Szczurek; Saskia Kreibich; Sabrina Dilling; Daniel Andritschke; Alain Casanova; Shyan Huey Low; Simone Eicher; Simone Muntwiler; Mario Emmenlauer; Pauli Rämö; Raquel Conde-Alvarez; Christian von Mering; Wolf-Dietrich Hardt; Christoph Dehio; Niko Beerenwinkel
Journal:  Genome Biol       Date:  2015-10-07       Impact factor: 13.583

9.  The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.

Authors:  Mark M Pomerantz; Fugen Li; David Y Takeda; Romina Lenci; Apurva Chonkar; Matthew Chabot; Paloma Cejas; Francisca Vazquez; Jennifer Cook; Ramesh A Shivdasani; Michaela Bowden; Rosina Lis; William C Hahn; Philip W Kantoff; Myles Brown; Massimo Loda; Henry W Long; Matthew L Freedman
Journal:  Nat Genet       Date:  2015-10-12       Impact factor: 38.330

10.  DGIdb 2.0: mining clinically relevant drug-gene interactions.

Authors:  Alex H Wagner; Adam C Coffman; Benjamin J Ainscough; Nicholas C Spies; Zachary L Skidmore; Katie M Campbell; Kilannin Krysiak; Deng Pan; Joshua F McMichael; James M Eldred; Jason R Walker; Richard K Wilson; Elaine R Mardis; Malachi Griffith; Obi L Griffith
Journal:  Nucleic Acids Res       Date:  2015-11-03       Impact factor: 16.971

View more
  613 in total

1.  Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines.

Authors:  Matthew G Rees; Brinton Seashore-Ludlow; Paul A Clemons
Journal:  Methods Mol Biol       Date:  2019

2.  Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples.

Authors:  Anshuman Panda; Anupama Yadav; Huwate Yeerna; Amartya Singh; Michael Biehl; Markus Lux; Alexander Schulz; Tyler Klecha; Sebastian Doniach; Hossein Khiabanian; Shridar Ganesan; Pablo Tamayo; Gyan Bhanot
Journal:  Nucleic Acids Res       Date:  2020-07-27       Impact factor: 16.971

Review 3.  Characterizing the ecological and evolutionary dynamics of cancer.

Authors:  Nastaran Zahir; Ruping Sun; Daniel Gallahan; Robert A Gatenby; Christina Curtis
Journal:  Nat Genet       Date:  2020-07-27       Impact factor: 38.330

Review 4.  Transcription Factor Inhibition: Lessons Learned and Emerging Targets.

Authors:  Andrew Chen; Angela N Koehler
Journal:  Trends Mol Med       Date:  2020-02-15       Impact factor: 11.951

5.  Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.

Authors:  Fleur M Ferguson; Zainab M Doctor; Scott B Ficarro; Christopher M Browne; Jarrod A Marto; Jared L Johnson; Tomer M Yaron; Lewis C Cantley; Nam Doo Kim; Taebo Sim; Matthew J Berberich; Marian Kalocsay; Peter K Sorger; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

6.  Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.

Authors:  Christopher J Lord; Niall Quinn; Colm J Ryan
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

7.  Targeting RET Kinase in Neuroendocrine Prostate Cancer.

Authors:  Halena R VanDeusen; Johnny R Ramroop; Katherine L Morel; Song Yi Bae; Anjali V Sheahan; Zoi Sychev; Nathan A Lau; Larry C Cheng; Victor M Tan; Zhen Li; Ashley Petersen; John K Lee; Jung Wook Park; Rendong Yang; Justin H Hwang; Ilsa Coleman; Owen N Witte; Colm Morrissey; Eva Corey; Peter S Nelson; Leigh Ellis; Justin M Drake
Journal:  Mol Cancer Res       Date:  2020-05-27       Impact factor: 5.852

Review 8.  How Machine Learning Will Transform Biomedicine.

Authors:  Jeremy Goecks; Vahid Jalili; Laura M Heiser; Joe W Gray
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

9.  Plasticity of ether lipids promotes ferroptosis susceptibility and evasion.

Authors:  Yilong Zou; Whitney S Henry; Emily L Ricq; Emily T Graham; Vaishnavi V Phadnis; Pema Maretich; Sateja Paradkar; Natalie Boehnke; Amy A Deik; Ferenc Reinhardt; John K Eaton; Bryan Ferguson; Wenyu Wang; Joshua Fairman; Heather R Keys; Vlado Dančík; Clary B Clish; Paul A Clemons; Paula T Hammond; Laurie A Boyer; Robert A Weinberg; Stuart L Schreiber
Journal:  Nature       Date:  2020-09-16       Impact factor: 49.962

10.  PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.

Authors:  Kristen S Hill; Evan R Roberts; Xue Wang; Ellen Marin; Taeeun D Park; Sorany Son; Yuan Ren; Bin Fang; Sean Yoder; Sungjune Kim; Lixin Wan; Amod A Sarnaik; John M Koomen; Jane L Messina; Jamie K Teer; Youngchul Kim; Jie Wu; Charles E Chalfant; Minjung Kim
Journal:  Mol Cancer Res       Date:  2018-10-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.